D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 84 Citations 49,872 326 World Ranking 9785 National Ranking 379

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Breast cancer

His scientific interests lie mostly in Breast cancer, Internal medicine, Radiation therapy, Oncology and Surgery. His Breast cancer research incorporates elements of Randomized controlled trial and Chemotherapy. In his work, Letrozole is strongly intertwined with Gynecology, which is a subfield of Internal medicine.

Timothy J. Whelan interconnects Meta-analysis and Systemic therapy in the investigation of issues within Radiation therapy. His Oncology research is multidisciplinary, incorporating elements of Prospective cohort study, Interquartile range, Incidence and Adjuvant therapy. His research integrates issues of Absolute risk reduction, Axillary lymph nodes, Lumpectomy and Heart disease in his study of Surgery.

His most cited work include:

  • Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango) (2716 citations)
  • Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials (2043 citations)
  • Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. (1691 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Breast cancer, Internal medicine, Oncology, Radiation therapy and Surgery. His study in Breast cancer is interdisciplinary in nature, drawing from both Stage and Randomized controlled trial. In his research on the topic of Internal medicine, Letrozole is strongly related with Gynecology.

His studies in Oncology integrate themes in fields like Clinical endpoint, Proportional hazards model, Hazard ratio, Hormonal therapy and Adjuvant therapy. His Radiation therapy research is multidisciplinary, incorporating perspectives in Whole Breast Irradiation, Lumpectomy and Medical physics. His Surgery research includes themes of Colorectal cancer and Breast pain.

He most often published in these fields:

  • Breast cancer (60.52%)
  • Internal medicine (51.01%)
  • Oncology (42.07%)

What were the highlights of his more recent work (between 2015-2021)?

  • Breast cancer (60.52%)
  • Internal medicine (51.01%)
  • Oncology (42.07%)

In recent papers he was focusing on the following fields of study:

Timothy J. Whelan mostly deals with Breast cancer, Internal medicine, Oncology, Radiation therapy and Randomized controlled trial. Breast cancer is a subfield of Cancer that Timothy J. Whelan explores. In his study, which falls under the umbrella issue of Internal medicine, Metformin and Gastroenterology is strongly linked to Placebo.

His Oncology research incorporates themes from Meta-analysis, Tamoxifen and Clinical trial. His research in Radiation therapy intersects with topics in Absolute risk reduction, Ductal carcinoma, Interquartile range and Lumpectomy. His Randomized controlled trial study is associated with Surgery.

Between 2015 and 2021, his most popular works were:

  • Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (685 citations)
  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. (494 citations)
  • Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years (300 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Breast cancer

His primary areas of study are Breast cancer, Internal medicine, Oncology, Radiation therapy and Cancer. His primary area of study in Breast cancer is in the field of Mastectomy. The various areas that Timothy J. Whelan examines in his Oncology study include Chemotherapy, Adjuvant therapy, Meta-analysis, Proportional hazards model and Stage.

His Radiation therapy study integrates concerns from other disciplines, such as Lung cancer, Interquartile range, Lumpectomy and Whole Breast Irradiation. His studies deal with areas such as Gene expression profiling and Pathology as well as Cancer. His work carried out in the field of Surgery brings together such families of science as McNemar's test and Deep inspiration breath-hold.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango)

Cathy Charles;Amiram Gafni;Tim Whelan.
Social Science & Medicine (1997)

4970 Citations

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials

S Darby;P McGale;C Correa.
The Lancet (2011)

3931 Citations

Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model.

Cathy Charles;Amiram Gafni;Tim Whelan.
Social Science & Medicine (1999)

2843 Citations

Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer

Timothy J Whelan;Jean-Philippe Pignol;Mark N Levine;Jim A Julian.
The New England Journal of Medicine (2010)

1709 Citations

Developing a quality criteria framework for patient decision aids: online international Delphi consensus process

Glyn Elwyn;Annette O'Connor;Dawn Stacey;Robert Volk.
(2006)

1696 Citations

American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

Eric P. Winer;Clifford Hudis;Harold J. Burstein;Antonio C. Wolff.
Journal of Clinical Oncology (2002)

1574 Citations

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

Joseph A. Sparano;Robert J. Gray;Della F. Makower;Kathleen I. Pritchard.
The New England Journal of Medicine (2018)

1396 Citations

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

P McGale;C. Taylor;C Correa.
The Lancet (2014)

1346 Citations

Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers

Eva Grunfeld;Doug Coyle;Timothy Whelan;Jennifer Clinch.
Canadian Medical Association Journal (2004)

1285 Citations

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

J. A. Sparano;R. J. Gray;D. F. Makower;K. I. Pritchard.
The New England Journal of Medicine (2015)

1256 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Timothy J. Whelan

Glyn Elwyn

Glyn Elwyn

Dartmouth Institute for Health Policy and Clinical Practice

Publications: 161

Frank A. Vicini

Frank A. Vicini

Beaumont Health

Publications: 112

Bruce G. Haffty

Bruce G. Haffty

Rutgers, The State University of New Jersey

Publications: 102

Monica Morrow

Monica Morrow

Memorial Sloan Kettering Cancer Center

Publications: 93

Thomas A. Buchholz

Thomas A. Buchholz

The University of Texas MD Anderson Cancer Center

Publications: 89

Phyllis Butow

Phyllis Butow

University of Sydney

Publications: 80

Roberto Orecchia

Roberto Orecchia

European Institute of Oncology

Publications: 76

Alain Fourquet

Alain Fourquet

Institute Curie

Publications: 72

Eric P. Winer

Eric P. Winer

Harvard University

Publications: 72

Ivo A. Olivotto

Ivo A. Olivotto

University of Calgary

Publications: 68

Reshma Jagsi

Reshma Jagsi

University of Michigan–Ann Arbor

Publications: 68

Adrian Edwards

Adrian Edwards

Cardiff University

Publications: 66

Paolo Veronesi

Paolo Veronesi

European Institute of Oncology

Publications: 59

Andreas Schneeweiss

Andreas Schneeweiss

German Cancer Research Center

Publications: 57

Kelly K. Hunt

Kelly K. Hunt

The University of Texas MD Anderson Cancer Center

Publications: 57

Amiram Gafni

Amiram Gafni

McMaster University

Publications: 56

Trending Scientists

Katalin F. Medzihradszky

Katalin F. Medzihradszky

University of California, San Francisco

Jose M. Goicoechea

Jose M. Goicoechea

University of Oxford

Jin Zhu

Jin Zhu

Chinese Academy of Sciences

Cheng-Xin Gong

Cheng-Xin Gong

City University of New York

Cheryl R. Kuske

Cheryl R. Kuske

Los Alamos National Laboratory

Edward J. Lesnefsky

Edward J. Lesnefsky

Virginia Commonwealth University

Morgane Bomsel

Morgane Bomsel

Université Paris Cité

Richard C. Dugdale

Richard C. Dugdale

San Francisco State University

Valérie Doyère

Valérie Doyère

University of Paris-Saclay

Kate E. Watkins

Kate E. Watkins

University of Oxford

Judith Semon Dubas

Judith Semon Dubas

Utrecht University

Reza Malekzadeh

Reza Malekzadeh

Tehran University of Medical Sciences

Jonathan M. Kalman

Jonathan M. Kalman

University of Melbourne

Christopher H. Schmid

Christopher H. Schmid

Brown University

Gary Remington

Gary Remington

Centre for Addiction and Mental Health

Philip C. Abrami

Philip C. Abrami

Concordia University

Something went wrong. Please try again later.